# DUSP1

## Overview
DUSP1, or dual specificity phosphatase 1, is a gene that encodes a protein belonging to the dual specificity phosphatase family, which is characterized by its ability to dephosphorylate both phospho-serine/threonine and phospho-tyrosine residues. The DUSP1 protein plays a pivotal role in the regulation of mitogen-activated protein kinase (MAPK) signaling pathways, acting as a nuclear enzyme that modulates cellular processes such as proliferation, apoptosis, and inflammation. By inactivating MAPKs, DUSP1 serves as a critical negative regulator of proinflammatory cytokine production, thereby maintaining immune homeostasis and preventing excessive inflammatory responses (Chi2006Dynamic; Kristiansen2012DUSP1). Additionally, DUSP1 is involved in metabolic regulation, offering protection against diet-induced obesity and influencing lipid metabolism (Bermudez2010The). The protein's interactions with MAPK family members, including JNK, ERK1/2, and p38, underscore its importance in cellular stress responses and its potential as a therapeutic target in inflammatory and autoimmune disorders (Shi2023DUSP1; Lang2019DualSpecificity).

## Structure
The human DUSP1 gene encodes a protein that is a dual specificity phosphatase, capable of dephosphorylating both phospho-serine/threonine and phospho-tyrosine residues. The full-length DUSP1 protein, known as transcript variant 1, consists of 367 amino acids and has a molecular weight of approximately 39 kDa. There are two additional transcript variants: variant 2, which encodes a shorter protein of 302 amino acids (32 kDa), and variant 3, which encodes a protein of 340 amino acids (36 kDa) (Kristiansen2012DUSP1).

DUSP1 features a catalytic domain typical of the protein tyrosine phosphatase family, characterized by a C-terminal cysteine-dependent active site sequence. This domain is responsible for its phosphatase activity. The non-catalytic N-terminal region of DUSP1 contains a rhodanese domain, which is known for catalyzing sulfur transfer reactions. This region also includes two areas of homology with sequences flanking the active site of the Cdc25 cell cycle regulatory phosphatase (Kristiansen2012DUSP1).

DUSP1 is involved in various cellular processes, including immune regulation and metabolic homeostasis, and has been shown to protect against inflammation and neuronal death in certain models (Kristiansen2012DUSP1). The protein may undergo post-translational modifications, such as phosphorylation, and exists in multiple isoforms due to alternative splicing.

## Function
DUSP1, also known as dual specificity phosphatase 1, is a nuclear enzyme that plays a critical role in the regulation of mitogen-activated protein kinase (MAPK) signaling pathways. It functions by dephosphorylating both phospho-threonine and phospho-tyrosine residues on MAPKs, thereby inactivating them and negatively regulating MAPK signaling (Kristiansen2012DUSP1). This regulation is essential for maintaining cellular homeostasis and is involved in various cellular processes, including proliferation, apoptosis, and the production of inflammatory molecules (Kristiansen2012DUSP1).

DUSP1 is particularly important in the immune system, where it acts as a negative regulator of proinflammatory cytokine production. It modulates the activation of p38 MAPK and JNK pathways, which are crucial for cytokine expression during immune responses (Chi2006Dynamic). By controlling the intensity and duration of MAPK activation, DUSP1 helps prevent excessive inflammatory responses, which can lead to conditions such as septic shock and autoimmune diseases (Hammer2005Dual; Salojin2006Essential).

In addition to its role in immune regulation, DUSP1 is involved in metabolic processes. It has been shown to protect against obesity induced by a high-fat diet and plays a role in lipid metabolism (Kristiansen2012DUSP1; Bermudez2010The). DUSP1's activity in these pathways underscores its importance in maintaining overall organismal health.

## Clinical Significance
DUSP1 plays a significant role in various diseases due to its involvement in the MAPK signaling pathway. In cancer, DUSP1 is overexpressed in early stages of epithelial tumors such as prostate, colon, and bladder cancers, but its expression decreases in advanced stages. This overexpression is linked to reduced apoptosis and increased chemoresistance, particularly in breast cancer, osteosarcoma, and non-small cell lung carcinoma, where it is associated with resistance to drugs like cisplatin and doxorubicin (Ruckert2019Protein; Bermudez2010The). In ovarian cancer, DUSP1 serves as a prognostic marker for shorter progression-free survival (Bermudez2010The).

In neurodegenerative diseases, DUSP1 downregulation is linked to increased pro-apoptotic signaling in Huntington's disease and cytotoxicity in Parkinson's disease, while its overexpression offers neuroprotection (PérezSen2019DualSpecificity). In Alzheimer's disease, DUSP1 downregulation correlates with glucocorticoid resistance and impaired synaptic plasticity (PérezSen2019DualSpecificity).

In polycythemia vera, DUSP1 is upregulated in JAK2V617F+ progenitor cells, aiding their survival under inflammatory stress. Inhibition of DUSP1 in these cells leads to increased apoptosis, suggesting its role in cell proliferation and survival (Stetka2019Addiction). These findings highlight DUSP1 as a potential therapeutic target in various diseases.

## Interactions
DUSP1, also known as MKP-1, is involved in several critical interactions with proteins, particularly within the MAPK signaling pathway. It directly interacts with the JNK protein, a part of the MAPK pathway, and this interaction is crucial for its role in dephosphorylating JNK, thereby regulating its activity. This interaction has been confirmed through co-immunoprecipitation experiments, which demonstrated that DUSP1 binds to JNK with a binding energy of -276.25 kcal/mol, indicating a stable interaction (Shi2023DUSP1). The interaction between DUSP1 and JNK is significant in the context of ischemic acute kidney injury, where DUSP1 helps stabilize mitochondrial DNA and prevent mitochondrial dysfunction by dephosphorylating JNK (Shi2023DUSP1).

DUSP1 also interacts with other MAPK family members, including ERK1/2 and p38, through an N-terminal MAPK-binding domain containing a kinase-interaction motif (Lang2019DualSpecificity). These interactions are essential for modulating cellular responses to stress and inflammation. In the context of immune signaling, DUSP1 is known to interact with MAPK8, as part of its regulatory role in immune cells (Subbannayya2019Dynamics). These interactions highlight DUSP1's role in controlling protein kinase activity and its potential as a therapeutic target in inflammatory and autoimmune disorders.


## References


[1. (Kristiansen2012DUSP1) M Kristiansen. Dusp1 (dual specificity phosphatase 1). Atlas of Genetics and Cytogenetics in Oncology and Haematology, November 2012. URL: http://dx.doi.org/10.4267/2042/48225, doi:10.4267/2042/48225. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.4267/2042/48225)

[2. (Ruckert2019Protein) Mariana Tannús Ruckert, Pamela Viani de Andrade, Verena Silva Santos, and Vanessa Silva Silveira. Protein tyrosine phosphatases: promising targets in pancreatic ductal adenocarcinoma. Cellular and Molecular Life Sciences, 76(13):2571–2592, April 2019. URL: http://dx.doi.org/10.1007/s00018-019-03095-4, doi:10.1007/s00018-019-03095-4. This article has 17 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1007/s00018-019-03095-4)

[3. (Hammer2005Dual) Michael Hammer, Jörg Mages, Harald Dietrich, Angela Servatius, Norma Howells, Andrew C.B. Cato, and Roland Lang. Dual specificity phosphatase 1 (dusp1) regulates a subset of lps-induced genes and protects mice from lethal endotoxin shock. The Journal of Experimental Medicine, 203(1):15–20, December 2005. URL: http://dx.doi.org/10.1084/jem.20051753, doi:10.1084/jem.20051753. This article has 272 citations.](https://doi.org/10.1084/jem.20051753)

[4. (Shi2023DUSP1) Lang Shi, Hongchu Zha, Zhou Pan, Jiayi Wang, Yao Xia, Huimin Li, Hua Huang, Ruchi Yue, Zhixia Song, and Jiefu Zhu. Dusp1 protects against ischemic acute kidney injury through stabilizing mtdna via interaction with jnk. Cell Death &amp; Disease, November 2023. URL: http://dx.doi.org/10.1038/s41419-023-06247-4, doi:10.1038/s41419-023-06247-4. This article has 9 citations.](https://doi.org/10.1038/s41419-023-06247-4)

[5. (Bermudez2010The) O. Bermudez, G. Pagès, and C. Gimond. The dual-specificity map kinase phosphatases: critical roles in development and cancer. American Journal of Physiology-Cell Physiology, 299(2):C189–C202, August 2010. URL: http://dx.doi.org/10.1152/ajpcell.00347.2009, doi:10.1152/ajpcell.00347.2009. This article has 173 citations.](https://doi.org/10.1152/ajpcell.00347.2009)

[6. (Stetka2019Addiction) J. Stetka, P. Vyhlidalova, L. Lanikova, P. Koralkova, J. Gursky, A. Hlusi, P. Flodr, S. Hubackova, J. Bartek, Z. Hodny, and V. Divoky. Addiction to dusp1 protects jak2v617f-driven polycythemia vera progenitors against inflammatory stress and dna damage, allowing chronic proliferation. Oncogene, 38(28):5627–5642, April 2019. URL: http://dx.doi.org/10.1038/s41388-019-0813-7, doi:10.1038/s41388-019-0813-7. This article has 33 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/s41388-019-0813-7)

[7. (Salojin2006Essential) Konstantin V. Salojin, Iris B. Owusu, Karen A. Millerchip, Mark Potter, Ken A. Platt, and Tamas Oravecz. Essential role of mapk phosphatase-1 in the negative control of innate immune responses. The Journal of Immunology, 176(3):1899–1907, February 2006. URL: http://dx.doi.org/10.4049/jimmunol.176.3.1899, doi:10.4049/jimmunol.176.3.1899. This article has 282 citations.](https://doi.org/10.4049/jimmunol.176.3.1899)

[8. (PérezSen2019DualSpecificity) Raquel Pérez-Sen, María José Queipo, Juan Carlos Gil-Redondo, Felipe Ortega, Rosa Gómez-Villafuertes, María Teresa Miras-Portugal, and Esmerilda G. Delicado. Dual-specificity phosphatase regulation in neurons and glial cells. International Journal of Molecular Sciences, 20(8):1999, April 2019. URL: http://dx.doi.org/10.3390/ijms20081999, doi:10.3390/ijms20081999. This article has 42 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms20081999)

[9. (Chi2006Dynamic) Hongbo Chi, Sean P. Barry, Rachel J. Roth, J. Julie Wu, Elizabeth A. Jones, Anton M. Bennett, and Richard A. Flavell. Dynamic regulation of pro- and anti-inflammatory cytokines by mapk phosphatase 1 (mkp-1) in innate immune responses. Proceedings of the National Academy of Sciences, 103(7):2274–2279, February 2006. URL: http://dx.doi.org/10.1073/pnas.0510965103, doi:10.1073/pnas.0510965103. This article has 478 citations.](https://doi.org/10.1073/pnas.0510965103)

[10. (Subbannayya2019Dynamics) Yashwanth Subbannayya, Sneha M. Pinto, Korbinian Bösl, T. S. Keshava Prasad, and Richard K. Kandasamy. Dynamics of dual specificity phosphatases and their interplay with protein kinases in immune signaling. International Journal of Molecular Sciences, 20(9):2086, April 2019. URL: http://dx.doi.org/10.3390/ijms20092086, doi:10.3390/ijms20092086. This article has 17 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms20092086)

[11. (Lang2019DualSpecificity) Roland Lang and Faizal Raffi. Dual-specificity phosphatases in immunity and infection: an update. International Journal of Molecular Sciences, 20(11):2710, June 2019. URL: http://dx.doi.org/10.3390/ijms20112710, doi:10.3390/ijms20112710. This article has 95 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms20112710)